Lv21
170 积分 2024-07-19 加入
1164 BSA01, a bispecific antibody-drug conjugate targeting EGFR and membrane-bound MUC-1-C, exhibits anti-tumor efficacyin vivo
6天前
已完结
Unlocking the power of nanomedicine: Cell membrane-derived biomimetic cancer nanovaccines for cancer treatment
17天前
已完结
The development of clinical guidelines on paracentesis for ascites related to malignancy
28天前
已完结
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
1个月前
已完结
Optical imaging of in vivo adoptive T‐cell therapy: State of the art and challenges
1个月前
已完结
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
1个月前
已完结
A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer
1个月前
已完结
Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer
1个月前
已完结
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
1个月前
已完结
Emerging functions and roles of circRNAs in cancer
皖公网安备34019202002308
